DMRANasdaq

Damora Therapeutics, Inc.

Alert me on DMRA

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Sep 28 Buy Jarrett Jennifer Insider

1 week

−2.6%S&P +1.2%

1 month

+5.8%S&P +0.5%

3 months

Result in33 trading days

6 months

Result in96 trading days

Jul 8 Sale Winslow Garrett Insider

1 week

+12.4%S&P +1.3%

1 month

+8.5%S&P +3.1%

3 months

−29.0%S&P +4.8%

6 months

Result in39 trading days

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for DMRA

24 held · newest 524 held · newest 2

Loading the filings.

See all 24 filings for DMRA

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

Sep 28 Insider

Jarrett Jennifer (CEO) bought $253K

A week later−2.6%S&P +1.2%

A month later+5.8%S&P +0.5%

Result in 33 trading days

Result in 96 trading days

Stakes

Jun 30, 2026 Schedule 13G

BlackRock, Inc.: 5.1%, 3,143,576 shares

Mar 31, 2026 Schedule 13G, amended

Point72 Asset Management, L.P.: 2%, 1,193,708 shares

Mar 31, 2026 Schedule 13G, amended

Jain Global LLC: 0%, 0 shares

Mar 31, 2026 Schedule 13G

Avoro Capital Advisors LLC: 6.3%, 3,783,000 shares

Feb 9, 2026 Schedule 13G, amended

Paramora Holding LLC: 3.4%, 2,045,473 shares

Feb 9, 2026 Schedule 13G, amended

Paragon Therapeutics, Inc.: 3.4%, 2,045,473 shares

Nov 30, 2025 Schedule 13G

Ikarian Capital, LLC: 21.5%, 285,710 shares

Nov 28, 2025 Schedule 13G

FMR LLC: 15%, 238,878 shares

Nov 10, 2025 Schedule 13D

Fairmount Funds Management LLC: 20%, 397,000 shares

Nov 12, 2025 Schedule 13G

Point72 Asset Management, L.P.: 6.3%, 100,001 shares

Oct 7, 2025 Schedule 13D, amended

Novo Holdings A/S: 0%, 0 shares

Sep 23, 2025 Schedule 13D, amended

Novo Holdings A/S: 6.5%, 86,579 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.